WALTHAM, MA-An emerging pharmaceutical company that develops molecular therapeutics to treat cancer and eye diseases has signed a four-year lease extension that added about 2,000 sf to its operations. Under the terms of the reworked deal, Oxigene Inc. now occupies 9,901 sf at 230 Third Ave. The company has been located in the six-story, 290,000-sf Prospect Place office for the past two years.

Charles Kavoogian, first vice president of CB Richard Ellis/Whittier Partners in Boston, tells GlobeSt.com that the expansion was prompted by the company’s recent development of a new drug, now in clinical trials, which required the firm to hire more regulatory and administrative staffers. Kavoogian, along with Matt Flaherty, vice president of CB Richard Ellis/Whittier Partners, represented the tenant. Negotiations for the owner, TA Associates, were handled by John Carroll III with Meredith & Grew’s Boston office along with colleague Elias Demakes and Frank Durand.

Carroll tells GlobeSt.com that the space was “not only able to support Oxigene’s recent growth, but was the right fit for them in the future.” Terms of the lease were not disclosed, but Kavoogian said the class A building with Route 128 frontage rents in the mid-$20 per-sf price range.

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM digital member, you’ll receive:

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications

*May exclude premium content
Already have an account?


© 2023 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Dig Deeper



Join GlobeSt

Don't miss crucial news and insights you need to make informed commercial real estate decisions. Join GlobeSt.com now!

  • Free unlimited access to GlobeSt.com's trusted and independent team of experts who provide commercial real estate owners, investors, developers, brokers and finance professionals with comprehensive coverage, analysis and best practices necessary to innovate and build business.
  • Exclusive discounts on ALM and GlobeSt events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com.

Already have an account? Sign In Now
Join GlobeSt

Copyright © 2023 ALM Global, LLC. All Rights Reserved.